Siebel Life Sciences CVE-2026-101451

Exploitation requires three concrete prerequisites: (1) the attacker holds a valid low-privileged account on the Siebel Life Sciences Web UI (PR:L), (2) network HTTP access to that Web UI (AV:N), and (3) interaction from a separate victim user other than the attacker (UI:R) - the attacker cannot self-trigger. The flaw affects the Web UI component across versions 17.0-26.9. Impact is limited to confidentiality and integrity with no availability effect (A:N), but the scope change (S:C) means successful exploitation can reach data and products beyond the attacker's own authorization boundary. Limiting factors for defenders: the dependency on both a foothold account and a victim's action substantially raises the bar versus a pure unauthenticated remote flaw.

This is a credible mid-to-high priority issue but not a drop-everything emergency on current evidence. The CVSS 3.1 vector (AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N, base 8.7) shows network reach and low attack complexity, but two factors meaningfully gate it: PR:L requires the attacker to already hold a low-privileged Siebel account, and UI:R requires a separate victim to interact. The elevated 8.7 score is driven largely by the scope change (S:C) plus high confidentiality and integrity impact, not by trivial unauthenticated access. No EPSS probability, CISA KEV listing, or public POC is present in the supplied data, so there is no signal of active or imminent exploitation - per the precision rules this is 'no public exploit identified at time of analysis.' The Oracle 'Easily exploitable' phrasing reflects AC:L, not the absence of prerequisites. Net: a real, patch-worthy flaw whose practical risk is bounded by the need for both a foothold account and victim interaction; treat it as a standard Oracle CPU remediation priority rather than a KEV-grade fire. Note a tag conflict: the input tag 'Authentication Bypass' is inconsistent with the vector, which explicitly requires privileges (PR:L) - verify, as the pattern (PR:L/UI:R/S:C/C:H/I:H/A:N) is the classic Oracle stored-XSS signature, not an auth bypass.

A low-privileged Siebel Life Sciences user stores a crafted payload through the Web UI, then a higher-value user (e.g., an administrator or clinical operations staffer) opens the affected view, causing the payload to execute in that victim's authenticated session. Because the scope changes, the attacker can read or tamper with critical data beyond their own privilege level and potentially reach additional connected products. No public exploit code is identified at time of analysis, so this would require attacker-developed tradecraft.